73 results on '"Ohneda K"'
Search Results
2. Regulation of GATA factor expression is distinct between erythroid and mast cell lineages
- Author
-
Ohmori, S. (Shin'ya), Takai, J. (Jun), Ishijima, Y. (Yasushi), Suzuki, M. (Masachika), Moriguchi, T. (Takashi), Philipsen, J.N.J. (Sjaak), Yamamoto, M. (Masayuki), Ohneda, K. (Kinuko), Ohmori, S. (Shin'ya), Takai, J. (Jun), Ishijima, Y. (Yasushi), Suzuki, M. (Masachika), Moriguchi, T. (Takashi), Philipsen, J.N.J. (Sjaak), Yamamoto, M. (Masayuki), and Ohneda, K. (Kinuko)
- Abstract
The zinc finger transcription factors GATA1 and GATA2 participate in mast cell development. Although the expression of these factors is regulated in a cell lineage-specific and differentiation stage-specific manner, their regulation during mast cell development has not been clarified. Here, we show that the GATA2 mRNA level was significantly increased while GATA1 was maintained at low levels during the differentiation of mast cells derived from mouse bone marrow (BMMCs). Unlike in erythroid cells, forced expression or small interfering RNA (siRNA)-mediated knockdown of GATA1 rarely affected GATA2 expression, and vice versa, in mast cells, indicating the absence of cross-regulation between Gata1 and Gata2 genes. Chromatin immunoprecipitation assays revealed that both GATA factors bound to most of the conserved GATA sites of Gata1 and Gata2 loci in BMMCs. However, the GATA1 hematopoietic enhancer (G1HE) of the Gata1 gene, which is essential for GATA1 expression in erythroid and megakaryocytic lineages, was bound only weakly by both GATA factors in BMMCs. Furthermore, transgenicmouse reporter assays revealed that the G1HE is not essential for reporter expression in BMMCs and peritoneal mast cells. Collectively, these results demonstrate that the expression of GATA factors in mast cells is regulated in a manner quite distinct from that in erythroid cells.
- Published
- 2012
- Full Text
- View/download PDF
3. Ablation of Gatal in adult mice results in aplastic crisis, revealing its essential role in steady-state and stress erythropoiesis
- Author
-
Gutiérrez, L. (Laura), Tsukamoto, S. (Saho), Suzuki, M. (Masachika), Yamamoto-Mukai, H. (Harumi), Yamamoto, M. (Masayuki), Philipsen, J.N.J. (Sjaak), Ohneda, K. (Kinuko), Gutiérrez, L. (Laura), Tsukamoto, S. (Saho), Suzuki, M. (Masachika), Yamamoto-Mukai, H. (Harumi), Yamamoto, M. (Masayuki), Philipsen, J.N.J. (Sjaak), and Ohneda, K. (Kinuko)
- Abstract
The transcription factor Gatal is expressed in several hematopoietic lineages and plays essential roles in normal hematopoietic development during embryonic stages. The lethality of Gata1-null embryos has precluded determination of its role in adult erythropoiesis. Here we have examined the effects of Gata1 loss in adult erythropoiesis using conditional Gatal knockout mice expressing either interferon-or tamoxifen-inducible Cre re- combinase (Mx-Cre and Tx-Cre, respectively). Mx-Cre-mediated Gatal recombi-nation, although incomplete, resulted in maturation arrest of Gata1-null erythroid cells at the proerythroblast stage, thrombocytopenia, and excessive proliferation of megakaryocytes in the spleen. Tx-Cre-mediated Gata1 recombination resulted in depletion of the erythroid compartment in bone marrow and spleen. Formation of the early and late erythroid progenitors in bone marrow was significantly reduced in the absence of Gata1. Furthermore, on treatment with a hemolytic agent, these mice failed to activate a stress erythropoietic response, despite the rising erythropoietin levels. These results indicate that, in addition to the requirement of Gata1 in adult megakaryopoiesis, Gatal is necessary for steady-state erythropoiesis and for erythroid expansion in response to anemia. Thus, ablation of Gatal in adult mice results in a condition resembling aplastic crisis in human.
- Published
- 2008
- Full Text
- View/download PDF
4. GATA1 function, a paradigm for transcription factors in hematopoiesis.
- Author
-
Ferreira, R. (Rita), Ohneda, K. (Kinuko), Yamamoto, M. (Masayuki), Philipsen, J.N.J. (Sjaak), Ferreira, R. (Rita), Ohneda, K. (Kinuko), Yamamoto, M. (Masayuki), and Philipsen, J.N.J. (Sjaak)
- Published
- 2005
- Full Text
- View/download PDF
5. Enhanced growth of small bowel in transgenic mice expressing human insulin-like growth factor I
- Author
-
Ohneda, K, primary, Ulshen, MH, additional, Fuller, CR, additional, D'Ercole, AJ, additional, and Lund, PK, additional
- Published
- 1997
- Full Text
- View/download PDF
6. Mechanism of insulin secretion by midaglizole
- Author
-
Ohneda, K., Ohneda, A., and Koizumi, F.
- Published
- 1993
- Full Text
- View/download PDF
7. Whole blood transcriptome analysis for age- and gender-specific gene expression profiling in Japanese individuals.
- Author
-
Aoki YI, Taguchi K, Anzawa H, Kawashima J, Ishida N, Otsuki A, Hasegawa A, Baird L, Suzuki T, Motoike IN, Ohneda K, Kumada K, Katsuoka F, Kinoshita K, and Yamamoto M
- Subjects
- Humans, Female, Male, Adult, Middle Aged, Japan, Aged, Young Adult, Age Factors, Sex Factors, Asian People genetics, East Asian People, Gene Expression Profiling methods, Transcriptome
- Abstract
Whole blood transcriptome analysis is a valuable approachin medical research, primarily due to the ease of sample collection and the richness of the information obtained. Since the expression profile of individual genes in the analysis is influenced by medical traits and demographic attributes such as age and gender, there has been a growing demand for a comprehensive database for blood transcriptome analysis. Here, we performed whole blood RNA sequencing (RNA-seq) analysis on 576 participants stratified by age (20-30s and 60-70s) and gender from cohorts of the Tohoku Medical Megabank (TMM). A part of female segment included pregnant women. We did not exclude the globin gene family in our RNA-seq study, which enabled us to identify instances of hereditary persistence of fetal hemoglobin based on the HBG1 and HBG2 expression information. Comparing stratified populations allowed us to identify groups of genes associated with age-related changes and gender differences. We also found that the immune response status, particularly measured by neutrophil-to-lymphocyte ratio (NLR), strongly influences the diversity of individual gene expression profiles in whole blood transcriptome analysis. This stratification has resulted in a data set that will be highly beneficial for future whole blood transcriptome analysis in the Japanese population., (© The Author(s) 2024. Published by Oxford University Press on behalf of the Japanese Biochemical Society.)
- Published
- 2024
- Full Text
- View/download PDF
8. [Return of Individual Genomic Results to Germline Pathogenic Variant Carriers of Hereditary Cancer in Population Based Cohort Study].
- Author
-
Ohneda K
- Subjects
- Female, Humans, Cohort Studies, Genetic Predisposition to Disease, Genomics, Germ Cells, Hereditary Breast and Ovarian Cancer Syndrome
- Abstract
Return of individual genomic results(ROGR)to participants in population-based biobank has been rarely conducted in research settings, and the procedure of ROGR performed in foreign countries may not be simply applied to Japanese participants, because of the difference in social background. The Tohoku Medical Megabank Project, which was launched in 2012 aiming to build a foundation of personalized genomic medicine, obtained the consent from research participants by explaining the future possibility of ROGR. After careful consideration of appropriate procedure for ROGR, individual genomic results were returned to 111 pathogenic variant(PV)carriers of hereditary breast and ovarian cancer syndrome(HBOC)or Lynch syndrome(LS)based on 50,000 whole genome sequencing(WGS)data in FY 2022. Since majority of the participants has no cancer diagnosis, participants' right to not know was carefully considered. In addition, the variants to be returned were carefully evaluated by using multiple databases, and the WGS results of the participants were further confirmed by the single- site analysis. When the genomic results were returned, the participants were informed about clinical risk surveillance at the hospital. Seventy-eight and 33 PV carriers of HBOC and LS, respectively, participated in the study. Most participants were in their 30s or 40s. Unexpectedly, validation testing results of 12 LS participants were found to be negative or variant of uncertain significance, because detecting these variants by WGS were technically challenging. Twenty-eight participants (HBOC 20, LS 8)had been diagnosed as cancer, and 6 females who had breast cancer were genetically diagnosed as HBOC and underwent or planned risk-reducing surgery. Eighteen participants refused to undergo clinical risk surveillance because of the medical expense that is not covered by health insurance and the burden of visiting the hospital. The opportunity to undergo medical surveillance should be provided to population-based cohort participants who carry actionable pathogenic variants, and ROGR to general population should be promoted to create the base of personalized genomic medicine.
- Published
- 2024
9. Effect of Nicotinamide Mononucleotide Concentration in Human Milk on Neurodevelopmental Outcome: The Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study.
- Author
-
Saito Y, Sato K, Jinno S, Nakamura Y, Nobukuni T, Ogishima S, Mizuno S, Koshiba S, Kuriyama S, Ohneda K, and Morifuji M
- Subjects
- Child, Preschool, Female, Infant, Humans, NAD, Cohort Studies, Nucleotides, Milk, Human, Nicotinamide Mononucleotide
- Abstract
(1) Background: Breast milk is the only source of nutrition for breastfed infants, but few studies have examined the relationship between breast milk micronutrients and infant neurodevelopmental outcome in exclusively breastfed infants. The aim of this study was to characterize the association between nicotinamide adenine dinucleotide (NAD)-related compounds in the breast milk of Japanese subjects and infant neurodevelopmental outcome. (2) Methods: A total of 150 mother-child pairs were randomly selected from the three-generation cohort of the Tohoku Medical Megabank in Japan. Infants were exclusively breastfed for up to 6 months. Breast milk was collected at 1 month postpartum, and the quantity of NAD-related substances in the breast milk was quantified. The mothers also completed developmental questionnaires at 6, 12, and 24 months. The relationship between the concentration of NAD-related substances in breast milk and developmental indicators was evaluated via ordinal logistic regression analysis. (3) Results: Nicotinamide mononucleotide (NMN) was quantified as the major NAD precursor in breast milk. The median amount of NMN in the breast milk was 9.2 μM. The NMN concentration in breast milk was the only NAD-related substance in breast milk that showed a significant positive correlation with neurodevelopmental outcome in infants at 24 months. (4) Conclusions: The results suggest that NMN in human milk may be an important nutrient for early childhood development.
- Published
- 2023
- Full Text
- View/download PDF
10. Returning individual genomic results to population-based cohort study participants with BRCA1/2 pathogenic variants.
- Author
-
Ohneda K, Hamanaka Y, Kawame H, Fuse N, Nagami F, Suzuki Y, Yamaguchi-Kabata Y, Shimada M, Masamune A, Aoki Y, Ishida T, and Yamamoto M
- Subjects
- Male, Humans, Female, Cohort Studies, BRCA1 Protein genetics, Genomics, Genetic Predisposition to Disease, BRCA2 Protein genetics, Breast Neoplasms genetics, Hereditary Breast and Ovarian Cancer Syndrome genetics, Ovarian Neoplasms genetics, Ovarian Neoplasms prevention & control
- Abstract
Background: Recent advances in human genome research have provided evidence for genotype-phenotype associations, pathogenicity, and clinical actionability of variants and genomic risk prediction of disease. However, the return of individual genomic results to healthy individuals is fraught with ethical and practical complexity., Methods: Individual genomic results were returned to BRCA1/2 pathogenic variant (PV) carriers of the Tohoku Medical Megabank cohort study participants with an information on hereditary breast and ovarian cancer syndrome (HBOC). One hundred and eighty participants, including 9 BRCA1/2 PV carriers, were asked about their willingness to receive individual genomic results, without revealing the gene name and related disorders, prior to the study. Of the 142 participants who responded, 103 showed willingness to know their genomic information. Each of the six BRCA1/2 PV carriers who consented to participate in the study received information about HBOC in person and underwent validation testing with blood resampling., Results: All participants were in their 60s or 70s; of the four females and two males, two had a history of breast cancer and five had a family history of HBOC-related cancers. All participants appreciated the information, without remarkable negative psychological impact of the return, and intended to undergo clinical risk surveillance. Five participants were accompanied by family members while receiving the results, and three first-degree female relatives wished to undergo genomic testing at the hospital., Conclusions: Our results suggest that returning actionable genomic information to participants in a population-based genome cohort study is beneficial for preventing or providing early-stage intervention for associated diseases., (© 2022. The Author(s), under exclusive licence to The Japanese Breast Cancer Society.)
- Published
- 2023
- Full Text
- View/download PDF
11. The Il6 -39 kb enhancer containing clustered GATA2- and PU.1-binding sites is essential for Il6 expression in murine mast cells.
- Author
-
Ohmori S, Takai J, Uemura S, Otsuki A, Mori T, Ohneda K, and Moriguchi T
- Abstract
Mast cells serve as a first-line defense of innate immunity. Interleukin-6 (IL-6) induced by bacterial lipopolysaccharide (LPS) in mast cells plays a crucial role in antibacterial protection. The zinc finger transcription factor GATA2 cooperatively functions with the ETS family transcription factor PU.1 in multiple mast cell activities. However, the regulatory landscape directed by GATA2 and PU.1 under inflammation remains elusive. We herein showed that a large proportion of GATA2-binding peaks were closely located with PU.1-binding peaks in distal cis -regulatory regions of inflammatory cytokine genes in mast cells. Notably, GATA2 and PU.1 played crucial roles in promoting LPS-mediated inflammatory cytokine production. Genetic ablation of GATA2-PU.1-clustered binding sites at the Il6 -39 kb region revealed its central role in LPS-induced Il6 expression in mast cells. We demonstrate a novel collaborative activity of GATA2 and PU.1 in cytokine induction upon inflammatory stimuli via the GATA2-PU.1 overlapping sites in the distal cis -regulatory regions., Competing Interests: The authors declare no conflicts of interest associated with this manuscript., (© 2022.)
- Published
- 2022
- Full Text
- View/download PDF
12. A Pilot Study for Return of Individual Pharmacogenomic Results to Population-Based Cohort Study Participants.
- Author
-
Ohneda K, Hiratsuka M, Kawame H, Nagami F, Suzuki Y, Suzuki K, Uruno A, Sakurai-Yageta M, Hamanaka Y, Taira M, Ogishima S, Kuriyama S, Hozawa A, Tomita H, Minegishi N, Sugawara J, Danjoh I, Nakamura T, Kobayashi T, Yamaguchi-Kabata Y, Tadaka S, Obara T, Hishimuma E, Mano N, Matsuura M, Sato Y, Nakasone M, Honkura Y, Suzuki J, Katori Y, Kakuta Y, Masamune A, Aoki Y, Nakayama M, Kure S, Kinoshita K, Fuse N, and Yamamoto M
- Abstract
Introduction: Pharmacogenomic (PGx) testing results provide valuable information on drug selection and appropriate dosing, maximization of efficacy, and minimization of adverse effects. Although the number of large-scale, next-generation-sequencing-based PGx studies has recently increased, little is known about the risks and benefits of returning PGx results to ostensibly healthy individuals in research settings., Methods: Single-nucleotide variants of three actionable PGx genes, namely, MT-RNR1 , CYP2C19 , and NUDT15 , were returned to 161 participants in a population-based Tohoku Medical Megabank project. Informed consent was obtained from the participants after a seminar on the outline of this study. The results were sent by mail alongside sealed information letter intended for clinicians. As an exception, genetic counseling was performed for the MT-RNR1 m.1555A > G variant carriers by a medical geneticist, and consultation with an otolaryngologist was encouraged. Questionnaire surveys (QSs) were conducted five times to evaluate the participants' understanding of the topic, psychological impact, and attitude toward the study., Results: Whereas the majority of participants were unfamiliar with the term PGx, and none had undergone PGx testing before the study, more than 80% of the participants felt that they could acquire basic PGx knowledge sufficient to understand their genomic results and were satisfied with their potential benefit and use in future prescriptions. On the other hand, some felt that the PGx concepts or terminology was difficult to fully understand and suggested that in-person return of the results was desirable., Conclusions: These results collectively suggest possible benefits of returning preemptive PGx information to ostensibly healthy cohort participants in a research setting., Competing Interests: None, (Copyright © Japan Medical Association.)
- Published
- 2022
- Full Text
- View/download PDF
13. The return of individual genomic results to research participants: design and pilot study of Tohoku Medical Megabank Project.
- Author
-
Kawame H, Fukushima A, Fuse N, Nagami F, Suzuki Y, Sakurai-Yageta M, Yasuda J, Yamaguchi-Kabata Y, Kinoshita K, Ogishima S, Takai T, Kuriyama S, Hozawa A, Nakaya N, Nakamura T, Minegishi N, Sugawara J, Suzuki K, Tomita H, Uruno A, Kobayashi T, Aizawa Y, Tokutomi T, Yamamoto K, Ohneda K, Kure S, Aoki Y, Katagiri H, Ishigaki Y, Sawada S, Sasaki M, and Yamamoto M
- Subjects
- Databases, Genetic, Disclosure, Humans, Japan, Pharmacogenetics, Pilot Projects, Research Design, Genetics, Medical, Genome, Genomics methods, Research
- Abstract
Certain large genome cohort studies attempt to return the individual genomic results to the participants; however, the implementation process and psychosocial impacts remain largely unknown. The Tohoku Medical Megabank Project has conducted large genome cohort studies of general residents. To implement the disclosure of individual genomic results, we extracted the potential challenges and obstacles. Major challenges include the determination of genes/disorders based on the current medical system in Japan, the storage of results, prevention of misunderstanding, and collaboration of medical professionals. To overcome these challenges, we plan to conduct multilayer pilot studies, which deal with different disorders/genes. We finally chose familial hypercholesterolemia (FH) as a target disease for the first pilot study. Of the 665 eligible candidates, 33.5% were interested in the pilot study and provided consent after an educational "genetics workshop" on the basic genetics and medical facts of FH. The genetics professionals disclosed the results to the participants. All positive participants were referred to medical care, and a serial questionnaire revealed no significant psychosocial distress after the disclosure. Return of genomic results to research participants was implemented using a well-prepared protocol. To further elucidate the impact of different disorders, we will perform multilayer pilot studies with different disorders, including actionable pharmacogenomics and hereditary tumor syndromes., (© 2021. The Author(s), under exclusive licence to The Japan Society of Human Genetics.)
- Published
- 2022
- Full Text
- View/download PDF
14. Rejuvenation of mesenchymal stem cells by extracellular vesicles inhibits the elevation of reactive oxygen species.
- Author
-
Khanh VC, Yamashita T, Ohneda K, Tokunaga C, Kato H, Osaka M, Hiramatsu Y, and Ohneda O
- Subjects
- Aging metabolism, Animals, Cellular Senescence physiology, Diabetes Mellitus, Experimental metabolism, Humans, MAP Kinase Signaling System, Mice, Superoxide Dismutase metabolism, Superoxide Dismutase-1 metabolism, Extracellular Vesicles physiology, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells metabolism, Reactive Oxygen Species metabolism, Rejuvenation physiology
- Abstract
Aging induces numerous cellular disorders, such as the elevation of reactive oxygen species (ROS), in a number type of cells, including mesenchymal stem cells (MSCs). However, the correlation of ROS and impaired healing abilities as well as whether or not the inhibition of elevating ROS results in the rejuvenation of elderly MSCs is unclear. The rejuvenation of aged MSCs has thus recently received attention in the field of regenerative medicine. Specifically, extracellular vesicles (EVs) act as a novel tool for stem cell rejuvenation due to their gene transfer ability with systemic effects and safety. In the present study, we examined the roles of aging-associated ROS in the function and rejuvenation of elderly MSCs by infant EVs. The data clearly showed that elderly MSCs exhibited the downregulation of superoxide dismutase (SOD)1 and SOD3, which resulted in the elevation of ROS and downregulation of the MEK/ERK pathways, which are involved in the impairment of the MSCs' ability to decrease necrotic area in the skin flap model. Furthermore, treatment with the antioxidant Edaravone or co-overexpression of SOD1 and SOD3 rescued elderly MSCs from the elevation of ROS and cellular senescence, thereby improving their functions. Of note, infant MSC-derived EVs rejuvenated elderly MSCs by inhibiting ROS production and the acceleration of cellular senescence and promoting the proliferation and in vivo functions in both type 1 and type 2 diabetic mice.
- Published
- 2020
- Full Text
- View/download PDF
15. GATA2 and PU.1 Collaborate To Activate the Expression of the Mouse Ms4a2 Gene, Encoding FcεRIβ, through Distinct Mechanisms.
- Author
-
Ohmori S, Ishijima Y, Numata S, Takahashi M, Sekita M, Sato T, Chugun K, Yamamoto M, and Ohneda K
- Subjects
- Animals, Bone Marrow Cells cytology, Chromatin Immunoprecipitation, DNA-Binding Proteins metabolism, GATA2 Transcription Factor genetics, Gene Expression Regulation, LIM Domain Proteins metabolism, Mast Cells metabolism, Mice, Mice, Knockout, Promoter Regions, Genetic, Proto-Oncogene Proteins genetics, RNA, Messenger genetics, RNA, Small Interfering genetics, Receptors, IgE metabolism, Trans-Activators genetics, GATA2 Transcription Factor metabolism, Proto-Oncogene Proteins metabolism, Receptors, IgE genetics, Trans-Activators metabolism
- Abstract
GATA factors GATA1 and GATA2 and ETS factor PU.1 are known to function antagonistically during hematopoietic development. In mouse mast cells, however, these factors are coexpressed and activate the expression of the Ms4a2 gene encoding the β chain of the high-affinity IgE receptor (FcεRI). The present study showed that these factors cooperatively regulate Ms4a2 gene expression through distinct mechanisms. Although GATA2 and PU.1 contributed almost equally to Ms4a2 gene expression, gene ablation experiments revealed that simultaneous knockdown of both factors showed neither a synergistic nor an additive effect. A chromatin immunoprecipitation analysis showed that they shared DNA binding to the +10.4-kbp region downstream of the Ms4a2 gene with chromatin looping factor LDB1, whereas the proximal -60-bp region was exclusively bound by GATA2 in a mast cell-specific manner. Ablation of PU.1 significantly reduced the level of GATA2 binding to both the +10.4-kbp and -60-bp regions. Surprisingly, the deletion of the +10.4-kbp region by genome editing completely abolished the Ms4a2 gene expression as well as the cell surface expression of FcεRI. These results suggest that PU.1 and LDB1 play central roles in the formation of active chromatin structure whereas GATA2 directly activates the Ms4a2 promoter., (Copyright © 2019 American Society for Microbiology.)
- Published
- 2019
- Full Text
- View/download PDF
16. Mouse Tryptase Gene Expression is Coordinately Regulated by GATA1 and GATA2 in Bone Marrow-Derived Mast Cells.
- Author
-
Ohneda K, Ohmori S, and Yamamoto M
- Subjects
- Animals, Gene Knockout Techniques, Genetic Loci, Mice, Promoter Regions, Genetic, Protein Binding, RNA, Small Interfering genetics, Tryptases metabolism, Bone Marrow Cells metabolism, GATA1 Transcription Factor metabolism, GATA2 Transcription Factor metabolism, Gene Expression Regulation, Mast Cells metabolism, Tryptases genetics
- Abstract
Mast cell tryptases have crucial roles in allergic and inflammatory diseases. The mouse tryptase genes represent a cluster of loci on chromosome 16p3.3. While their functional studies have been extensively performed, transcriptional regulation of tryptase genes is poorly understood. In this study, we examined the molecular basis of the tryptase gene expression in bone marrow-derived mast cells (BMMCs) of C57BL/6 mice and in MEDMC-BRC6 mast cells. The expression of the Tpsb2 and Tpsg1 genes, which reside at the 3'-end of the tryptase locus, is significantly decreased by the reduction of the GATA transcription factors GATA1 or GATA2. Chromatin immunoprecipitation assays have shown that the GATA factors bind at multiple regions within the locus, including 1.0 and 72.8 kb upstream of the Tpsb2 gene, and that GATA1 and GATA2 facilitate each other's DNA binding activity to these regions. Deletion of the -72.8 kb region by genome editing significantly reduced the Tpsb2 and Tpsg1 mRNA levels in MEDMC-BRC6 cells. Furthermore, binding of CTCF and the cohesin subunit Rad21 was found upstream of the -72.8 kb region and was significantly reduced in the absence of GATA1. These results suggest that mouse tryptase gene expression is coordinately regulated by GATA1 and GATA2 in BMMCs., Competing Interests: The authors declare no conflicts of interest.
- Published
- 2019
- Full Text
- View/download PDF
17. The Gata2 repression during 3T3-L1 preadipocyte differentiation is dependent on a rapid decrease in histone acetylation in response to glucocorticoid receptor activation.
- Author
-
Ishijima Y, Ohmori S, Uneme A, Aoki Y, Kobori M, Ohida T, Arai M, Hosaka M, and Ohneda K
- Subjects
- 3T3-L1 Cells, Acetylation, Adipocytes metabolism, Animals, Cell Differentiation, Down-Regulation, Epigenesis, Genetic, GATA2 Transcription Factor metabolism, Gene Expression Regulation, Mice, Promoter Regions, Genetic, Transcriptional Activation, Adipocytes cytology, GATA2 Transcription Factor genetics, Histones metabolism, Receptors, Glucocorticoid metabolism
- Abstract
The transcription factor GATA2 is an anti-adipogenic factor whose expression is downregulated during adipocyte differentiation. The present study attempted to clarify the molecular mechanism underlying the GATA2 repression and found that the repression is dependent on the activation of the glucocorticoid receptor (GR) during 3T3-L1 preadipocyte differentiation. Although several recognition sequences for GR were found in both the proximal and distal regions of the Gata2 locus, the promoter activity was not affected by the GR activation in the reporter assays, and the CRISPR-Cas9-mediated deletion of the two distal regions of the Gata2 locus was not involved in the GR-mediated Gata2 repression. Notably, the level of histone acetylation was markedly reduced at the Gata2 locus during 3T3-L1 differentiation, and the GR-mediated Gata2 repression was significantly relieved by histone deacetylase inhibition. These results suggest that GR regulates the Gata2 gene by reducing histone acetylation in the early phase of adipogenesis., (Copyright © 2019 Elsevier B.V. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
18. Uremic Toxins Affect the Imbalance of Redox State and Overexpression of Prolyl Hydroxylase 2 in Human Adipose Tissue-Derived Mesenchymal Stem Cells Involved in Wound Healing.
- Author
-
Khanh VC, Ohneda K, Kato T, Yamashita T, Sato F, Tachi K, and Ohneda O
- Subjects
- Adipose Tissue metabolism, Adipose Tissue pathology, Animals, Disease Models, Animal, Gene Expression Regulation, Humans, Hypoxia-Inducible Factor 1, alpha Subunit metabolism, Hypoxia-Inducible Factor-Proline Dioxygenases genetics, Mesenchymal Stem Cell Transplantation, Mice, Reactive Oxygen Species metabolism, Renal Insufficiency, Chronic metabolism, Wound Healing physiology, Hypoxia-Inducible Factor 1, alpha Subunit genetics, Hypoxia-Inducible Factor-Proline Dioxygenases metabolism, Mesenchymal Stem Cells metabolism, Wound Healing genetics
- Abstract
Chronic kidney disease (CKD) results in a delay in wound healing because of its complications such as uremia, anemia, and fluid overload. Mesenchymal stem cells (MSCs) are considered to be a candidate for wound healing because of the ability to recruit many types of cells. However, it is still unclear whether the CKD-adipose tissue-derived MSCs (CKD-AT-MSCs) have the same function in wound healing as healthy donor-derived normal AT-MSCs (nAT-MSCs). In this study, we found that uremic toxins induced elevated reactive oxygen species (ROS) expression in nAT-MSCs, resulting in the reduced expression of hypoxia-inducible factor-1α (HIF-1α) under hypoxic conditions. Consistent with the uremic-treated AT-MSCs, there was a definite imbalance of redox state and high expression of ROS in CKD-AT-MSCs isolated from early-stage CKD patients. In addition, a transplantation study clearly revealed that nAT-MSCs promoted the recruitment of inflammatory cells and recovery from ischemia in the mouse flap model, whereas CKD-AT-MSCs had defective functions and the wound healing process was delayed. Of note, the expression of prolyl hydroxylase domain 2 (PHD2) is selectively increased in CKD-AT-MSCs and its inhibition can restore the expression of HIF-1α and the wound healing function of CKD-AT-MSCs. These results indicate that more studies about the functions of MSCs from CKD patients are required before they can be applied in the clinical setting.
- Published
- 2017
- Full Text
- View/download PDF
19. Microvesicles derived from Alde-Low EPCs support the wound healing capacity of AT-MSCs.
- Author
-
Tu TC, Yamashita T, Kato T, Nagano M, Trinh NT, Hamada H, Sato F, Ohneda K, Matsuo-Takasaki M, and Ohneda O
- Subjects
- Animals, Mice, Mice, Inbred C57BL, Endothelial Progenitor Cells cytology, Mesenchymal Stem Cells cytology, Wound Healing
- Abstract
Mesenchymal stem cells (MSCs) are defined as multipotent cells that can give rise to various kinds of differentiated mesenchymal cells, and are thus considered to be useful for clinical therapy. However, the big hurdles of MSC therapy are the inability of MSCs to reach the appropriate tissues or sites with high efficiency and engraftment after transplantation. In this study, we investigated how adipose tissue-derived MSCs (AT-MSCs) improve their homing ability after intravenous injection. We previously found that human endothelial progenitor cells with low aldehyde dehydrogenase activity (Alde-Low EPCs) are suitable for the treatment of ischemic tissues. In addition, we demonstrated that microvesicles (MVs) derived from Alde-Low EPCs possessed the ability to improve the homing ability of non-functional Alde-High EPCs, resulting in wound healing. We initially transfected MVs derived from Alde-Low EPCs (EMVs) to human AT-MSCs, which were originally unable to cure ischemic tissues by intravenous transplantation. Remarkably, AT-MSC transfected EMVs dramatically repaired the ischemic skin flap compared with AT-MSC derived-MV (MMVs) transfected AT-MSCs or control AT-MSCs. We then found that the expression of CXCR4, an important chemokine receptor for cell migration, was highly elevated in EMV-transfected AT-MSCs. Moreover, AT-MSCs transfected with EMVs, but not control AT-MSCs, migrated to wound sites after intravenous injection. Consequently, CD45(+) inflammatory cells were successfully recruited at the wound sites after the injection of EMV-transfected AT-MSCs. These results demonstrate that EMVs are a useful source to improve the homing ability and wound healing ability of MSCs at the wound sites., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
20. Increased Expression of EGR-1 in Diabetic Human Adipose Tissue-Derived Mesenchymal Stem Cells Reduces Their Wound Healing Capacity.
- Author
-
Trinh NT, Yamashita T, Ohneda K, Kimura K, Salazar GT, Sato F, and Ohneda O
- Subjects
- Animals, Biomarkers metabolism, Cell Differentiation, Cell Membrane metabolism, Extracellular Signal-Regulated MAP Kinases metabolism, Female, Humans, Male, Mice, Inbred C57BL, Middle Aged, Skin pathology, Surgical Flaps, Adipose Tissue pathology, Diabetes Mellitus, Type 2 pathology, Early Growth Response Protein 1 metabolism, Mesenchymal Stem Cells metabolism, Wound Healing
- Abstract
The prevalence of type 2 diabetes mellitus (T2DM), which leads to diabetic complications, has been increasing worldwide. The possible applications of T2DM-derived stem cells in cell therapy are limited because their characteristics are still not fully understood. In this study, we characterized adipose tissue-derived mesenchymal stem cells (AT-MSCs) from diabetic patients (dAT-MSCs) and found that insulin receptor substrate-1 (IRS-1) was highly phosphorylated at serine 636/639 in dAT-MSCs. Moreover, we found that early growth response factor-1 (EGR-1) and its target genes of PTEN and GGPS1 were highly expressed in dAT-MSCs in comparison to healthy donor-derived AT-MSCs (nAT-MSCs). We observed impaired wound healing after the injection of dAT-MSCs in the ischemic flap mouse model. The expressions of EGR-1 and its target genes were diminished by small hairpin RNA-targeted EGR-1 (shEGR-1) and treatment with a mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) inhibitor (PD98059). Importantly, dAT-MSCs with shEGR-1 were able to restore the wound healing ability in the mouse model. Interestingly, under hypoxic conditions, hypoxia-inducible factor-1α (HIF-1α) can bind to the EGR-1 promoter in dAT-MSCs, but not in nAT-MSCs. Together, these results demonstrate that the expression of EGR-1 was upregulated in dAT-MSCs through two pathways: the main regulatory pathway is the MAPK/ERK pathway, the other is mediated by HIF-1α through direct transcriptional activation at the promoter region of the EGR1 gene. Our study suggests that dAT-MSCs may contribute to microvascular damage and delay wound healing through the overexpression of EGR-1. Interrupting the expression of EGR-1 in dAT-MSCs may be a useful treatment for chronic wounds in diabetic patients.
- Published
- 2016
- Full Text
- View/download PDF
21. Microvesicles enhance the mobility of human diabetic adipose tissue-derived mesenchymal stem cells in vitro and improve wound healing in vivo.
- Author
-
Trinh NT, Yamashita T, Tu TC, Kato T, Ohneda K, Sato F, and Ohneda O
- Subjects
- Animals, Cell Movement, Cell-Derived Microparticles pathology, Cell-Derived Microparticles physiology, Female, Mesenchymal Stem Cells pathology, Mice, Mice, Inbred C57BL, Treatment Outcome, Adipocytes cytology, Cell-Derived Microparticles transplantation, Diabetes Mellitus, Type 2 pathology, Mesenchymal Stem Cell Transplantation methods, Mesenchymal Stem Cells physiology, Wound Healing physiology
- Abstract
Microvesicles (MVs) derived from mesenchymal stem cells showed the ability to alter the cell phenotype and function. We previously demonstrated that type 2 diabetic adipose tissue-derived mesenchymal stem cells (dAT-MSCs) increase in cell aggregation and adhesion in vitro and impair wound healing in vivo. However, the characterization and function of MVs derived from human non-diabetic AT-MSCs (nAT-MSCs) remain unknown. In this study, we characterized nAT-MSC-derived MVs and their function after the transfection of dAT-MSCs with MVs using the scratch assay and a flap mouse model. We found that human nAT-MSC-derived MVs expressed MSC-surface markers and improved dAT-MSC functions by altering the expression of genes associated with cell migration, survival, inflammation, and angiogenesis as well as miR29c and miR150. Remarkably, the transfection of dAT-MSCs with nAT-MSC-derived MVs improved their migration ability in vitro and wound healing ability in a flap mouse model. These results demonstrate a promising opportunity to modify the function of dAT-MSCs for therapeutic stem cell application in diabetic patients., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
22. A Chemokine Receptor, CXCR4, Which Is Regulated by Hypoxia-Inducible Factor 2α, Is Crucial for Functional Endothelial Progenitor Cells Migration to Ischemic Tissue and Wound Repair.
- Author
-
Tu TC, Nagano M, Yamashita T, Hamada H, Ohneda K, Kimura K, and Ohneda O
- Subjects
- Aldehyde Dehydrogenase metabolism, Animals, Basic Helix-Loop-Helix Transcription Factors genetics, Chemokine CXCL12 metabolism, Endothelial Progenitor Cells cytology, Endothelial Progenitor Cells physiology, Humans, Ischemia metabolism, Mice, Mice, Inbred C57BL, Promoter Regions, Genetic, Protein Binding, Receptors, CXCR4 genetics, Skin blood supply, Skin metabolism, Basic Helix-Loop-Helix Transcription Factors metabolism, Cell Movement, Endothelial Progenitor Cells metabolism, Receptors, CXCR4 metabolism, Wound Healing
- Abstract
Endothelial progenitor cells (EPCs) have the ability to form new blood vessels and protect ischemic tissues from damage. We previously reported that EPCs with low activity of aldehyde dehydrogenase (Alde-Low EPCs) possess the greater ability to treat ischemic tissues compared with Alde-High EPCs. The expression level of the hypoxia-inducible factors (HIFs), HIF-1α and HIF-2α, was found to be greater in Alde-Low EPCs than in Alde-High EPCs. However, the precise role of the HIF factors in the regulation of EPC activity remains obscure. In this study, we demonstrate a critical role of HIF-2α and its target gene CXCR4 for controlling the migratory activity of EPC to ischemic tissue. We found that coculture of Alde-High EPCs with microvesicles derived from Alde-Low EPCs improved their ability to repair an ischemic skin flap, and the expression of CXCR4 and its ligand SDF1 was significantly increased following the coculture. In Alde-Low EPCs, the expression of CXCR4 was suppressed by short hairpin RNA (shRNA)-mediated HIF-2α, but not HIF-1α downregulation. Chromatin immunoprecipitation assays showed that HIF-2α, but not HIF-1α, binds to the promoter region of CXCR4 gene. The CXCR4 shRNA treatment in Alde-Low EPCs almost completely abrogated their migratory activity to ischemic tissues, whereas the reduction of vascular endothelial growth factor (VEGF) showed much less effect. The CXCR4 overexpression in Alde-High EPCs resulted in a partial, but significant improvement in their repairing ability in an ischemic skin flap. Collectively, these findings indicate that the CXCR4/SDF-1 axis, which is specifically regulated by HIF-2α, plays a crucial role in the regulation of EPC migration to ischemic tissues.
- Published
- 2016
- Full Text
- View/download PDF
23. GATA2 is critical for the maintenance of cellular identity in differentiated mast cells derived from mouse bone marrow.
- Author
-
Ohmori S, Moriguchi T, Noguchi Y, Ikeda M, Kobayashi K, Tomaru N, Ishijima Y, Ohneda O, Yamamoto M, and Ohneda K
- Subjects
- Animals, Blotting, Western, Cell Differentiation immunology, Chromatin Immunoprecipitation, Flow Cytometry, GATA2 Transcription Factor immunology, Mast Cells metabolism, Mice, Mice, Knockout, Reverse Transcriptase Polymerase Chain Reaction, Bone Marrow Cells cytology, Cell Dedifferentiation immunology, GATA2 Transcription Factor metabolism, Mast Cells cytology, Stem Cells cytology
- Abstract
GATA2 plays a crucial role for the mast cell fate decision. We herein demonstrate that GATA2 is also required for the maintenance of the cellular identity in committed mast cells derived from mouse bone marrow (BMMCs). The deletion of the GATA2 DNA binding domain (GATA2ΔCF) in BMMCs resulted in a loss of the mast cell phenotype and an increase in the number of CD11b- and/or Ly6G/C-positive cells. These cells showed the ability to differentiate into macrophage- and neutrophil-like cells but not into eosinophils. Although the mRNA levels of basophil-specific genes were elevated, CD49b, a representative basophil marker, never appeared on these cells. GATA2 ablation led to a significant upregulation of C/EBPα, and forced expression of C/EBPα in wild-type BMMCs phenocopied the GATA2ΔCF cells. Interestingly, simultaneous deletion of the Gata2 and Cebpa genes in BMMCs restored the aberrant increases of CD11b and Ly6G/C while retaining the reduced c-Kit expression. Chromatin immunoprecipitation assays indicated that GATA2 directly binds to the +37-kb region of the Cebpa gene and thereby inhibits the RUNX1 and PU.1 binding to the neighboring region. Upregulation of C/EBPα following the loss of GATA2 was not observed in cultured mast cells derived from peritoneal fluid, whereas the repression of c-Kit and other mast cell-specific genes were observed in these cells. Collectively, these results indicate that GATA2 maintains cellular identity by preventing Cebpa gene activation in a subpopulation of mast cells, whereas it plays a fundamental role as a positive regulator of mast cell-specific genes throughout development of this cell lineage., (© 2015 by The American Society of Hematology.)
- Published
- 2015
- Full Text
- View/download PDF
24. The Human GATA1 Gene Retains a 5' Insulator That Maintains Chromosomal Architecture and GATA1 Expression Levels in Splenic Erythroblasts.
- Author
-
Moriguchi T, Yu L, Takai J, Hayashi M, Satoh H, Suzuki M, Ohneda K, and Yamamoto M
- Subjects
- Animals, Binding Sites, CCCTC-Binding Factor, Cells, Cultured, Chromatin physiology, Chromosomes, Artificial, Bacterial genetics, GATA1 Transcription Factor chemistry, GATA1 Transcription Factor metabolism, Genetic Vectors genetics, Humans, K562 Cells, Mice, Mice, Transgenic, Repressor Proteins metabolism, Spleen metabolism, Chromosomes genetics, Erythroblasts metabolism, GATA1 Transcription Factor genetics, Insulator Elements, Spleen cytology
- Abstract
GATA1 is a key transcription factor for erythropoiesis. GATA1 gene expression is strictly regulated at the transcriptional level. While the regulatory mechanisms governing mouse Gata1 (mGata1) gene expression have been studied extensively, how expression of the human GATA1 (hGATA1) gene is regulated remains to be elucidated. To address this issue, we generated hGATA1 bacterial artificial chromosome (BAC) transgenic mouse lines harboring a 183-kb hGATA1 locus covering the hGATA1 exons and distal flanking sequences. Transgenic hGATA1 expression coincides with endogenous mGata1 expression and fully rescues hematopoietic deficiency in mGata1 knockdown mice. The transgene exhibited copy number-dependent and integration position-independent expression of hGATA1, indicating the presence of chromatin insulator activity within the transgene. We found a novel insulator element at 29 kb 5' to the hGATA1 gene and refer to this element as the 5' CCCTC-binding factor (CTCF) site. Substitution mutation of the 5' CTCF site in the hGATA1 BAC disrupted the chromatin architecture and led to a reduction of hGATA1 expression in splenic erythroblasts under conditions of stress erythropoiesis. Our results demonstrate that expression of the hGATA1 gene is regulated through the chromatin architecture organized by 5' CTCF site-mediated intrachromosomal interactions in the hGATA1 locus., (Copyright © 2015, American Society for Microbiology. All Rights Reserved.)
- Published
- 2015
- Full Text
- View/download PDF
25. Hypoxia-inducible factor-3α promotes angiogenic activity of pulmonary endothelial cells by repressing the expression of the VE-cadherin gene.
- Author
-
Kobayashi S, Yamashita T, Ohneda K, Nagano M, Kimura K, Nakai H, Poellinger L, and Ohneda O
- Subjects
- Angiogenic Proteins metabolism, Animals, Antigens, CD genetics, Apoptosis Regulatory Proteins, Cadherins genetics, Cell Hypoxia, Lung blood supply, Mice, Mice, Transgenic, Proto-Oncogene Proteins c-akt metabolism, Repressor Proteins, Vascular Endothelial Growth Factor A metabolism, Antigens, CD metabolism, Cadherins metabolism, Endothelial Cells metabolism, Lung cytology, Neovascularization, Physiologic, Transcription Factors genetics, Transcription Factors metabolism
- Abstract
The variants of the hypoxia-inducible factor-3α gene HIF-3α and NEPAS are known to repress the transcriptional activities driven by HIF-1α and HIF-2α. Although NEPAS has been shown to play an important role in vascular remodeling during lung development, little is known about the roles of HIF-3α in adult lung function. Here, we examined pulmonary endothelial cells (ECs) isolated from wild-type (WT) and HIF-3α functional knockout (KO) mice. The expression levels of angiogenic factors (Flk1, Ang2 and Tie2) were significantly greater in the HIF-3α KO ECs than those in the WT ECs irrespective of oxygen tension. However, the HIF-3α KO ECs showed impaired proliferative and angiogenic activities. The impaired EC function was likely due to the excess vascular endothelial (VE)-cadherin, an inhibitor of Flk1/PI3 kinase/Akt signaling, as treatment of the cells to a neutralizing antibody partly restored the phenotype of the HIF-3α KO ECs. Importantly, we found that the mRNA levels of HIF-2α and Ets-1 were significantly increased by HIF-3α ablation. Given that both factors are known to activate the VE-cadherin gene, the transcriptional repression of these factors by HIF-3α might be important for silencing the irrelevant expression of the VE-cadherin gene. Collectively, these data show novel and unique roles of HIF-3α for angiogenic gene regulation in pulmonary ECs., (© 2015 The Authors Genes to Cells © 2015 by the Molecular Biology Society of Japan and Wiley Publishing Asia Pty Ltd.)
- Published
- 2015
- Full Text
- View/download PDF
26. Progenitor stage-specific activity of a cis-acting double GATA motif for Gata1 gene expression.
- Author
-
Moriguchi T, Suzuki M, Yu L, Takai J, Ohneda K, and Yamamoto M
- Subjects
- Alleles, Amino Acid Motifs, Animals, Cell Separation, Chromatin Immunoprecipitation, Chromosomes, Artificial, Bacterial, Erythropoiesis, Female, Flow Cytometry, GATA2 Transcription Factor metabolism, Gene Deletion, Genes, Reporter, Green Fluorescent Proteins metabolism, Homeostasis, Introns, Male, Mice, Mice, Transgenic, Mutation, Protein Binding, Erythroblasts cytology, GATA1 Transcription Factor metabolism, Gene Expression Regulation, Hematopoietic Stem Cells cytology
- Abstract
GATA1 is a master regulator of erythropoiesis, expression of which is regulated by multiple discrete cis-acting elements. In this study, we examine the activity of a promoter-proximal double GATA (dbGATA) motif, using a Gata1 bacterial artificial chromosome (BAC)-transgenic green fluorescent protein (GFP) reporter (G1BAC-GFP) mouse system. Deletion of the dbGATA motif led to significant reductions in GFP expression in hematopoietic progenitors, while GFP expression was maintained in erythroblasts. Consistently, in mice with a germ line deletion of the dbGATA motif (Gata1(ΔdbGATA) mice), GATA1 expression in progenitors was significantly decreased. The suppressed GATA1 expression was associated with a compensatory increase in GATA2 levels in progenitors. When we crossed Gata1(ΔdbGATA) mice with Gata2 hypomorphic mutant mice (Gata2(fGN/fGN) mice), the Gata1(ΔdbGATA)::Gata2(fGN/fGN) compound mutant mice succumbed to a significant decrease in the progenitor population, whereas both groups of single mutant mice maintained progenitors and survived to adulthood, indicating the functional redundancy between GATA1 and GATA2 in progenitors. Meanwhile, the effects of the dbGATA site deletion on Gata1 expression were subtle in erythroblasts, which showed increased GATA1 binding and enhanced accumulation of active histone marks around the 1st-intron GATA motif of the ΔdbGATA locus. These results thus reveal a novel role of the dbGATA motif in the maintenance of Gata1 expression in hematopoietic progenitors and a functional compensation between the dbGATA site and the 1st-intron GATA motif in erythroblasts., (Copyright © 2015, American Society for Microbiology. All Rights Reserved.)
- Published
- 2015
- Full Text
- View/download PDF
27. Transcription factor GATA1 is dispensable for mast cell differentiation in adult mice.
- Author
-
Ohneda K, Moriguchi T, Ohmori S, Ishijima Y, Satoh H, Philipsen S, and Yamamoto M
- Subjects
- Animals, Base Sequence, Bone Marrow Cells cytology, Bone Marrow Cells metabolism, Cells, Cultured, Chromosomes, Mammalian, Culture Media, Gene Expression Regulation, Enzymologic, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Molecular Sequence Data, Transcriptome, Tryptases genetics, Tryptases metabolism, Cell Differentiation, GATA1 Transcription Factor physiology, GATA2 Transcription Factor physiology, Mast Cells physiology
- Abstract
Although previous studies have shown that GATA1 is required for mast cell differentiation, the effects of the complete ablation of GATA1 in mast cells have not been examined. Using conditional Gata1 knockout mice (Gata1(-/y)), we demonstrate here that the complete ablation of GATA1 has a minimal effect on the number and distribution of peripheral tissue mast cells in adult mice. The Gata1(-/y) bone marrow cells were capable of differentiating into mast cells ex vivo. Microarray analyses showed that the repression of GATA1 in bone marrow mast cells (BMMCs) has a small impact on the mast cell-specific gene expression in most cases. Interestingly, however, the expression levels of mast cell tryptases in the mouse chromosome 17A3.3 were uniformly reduced in the GATA1 knockdown cells, and GATA1 was found to bind to a 500-bp region at the 5' end of this locus. Revealing a sharp contrast to that observed in the Gata1-null BMMCs, GATA2 deficiency resulted in a significant loss of the c-Kit(+) FcεRIα(+) mast cell fraction and a reduced expression of several mast cell-specific genes. Collectively, GATA2 plays a more important role than GATA1 in the regulation of most mast cell-specific genes, while GATA1 might play specific roles in mast cell functions.
- Published
- 2014
- Full Text
- View/download PDF
28. Mast cell deficiency results in the accumulation of preadipocytes in adipose tissue in both obese and non-obese mice.
- Author
-
Ishijima Y, Ohmori S, and Ohneda K
- Abstract
Mast cells have been suggested to play key roles in adipogenesis. We herein show that the expression of preadipocyte, but not adipocyte, marker genes increases in the white adipose tissue of mast cell-deficient (Kit(W-sh/W-sh) ) mice under both obese and non-obese conditions. In vitro culturing with adipogenic factors revealed increased adipocytes differentiated from the Kit(W-sh/W-sh) stromal vascular fraction, suggesting the accumulation of preadipocytes. Moreover, the increased expression of preadipocyte genes was restored by mast cell reconstitution in the Kit(W-sh/W-sh) mice. These results suggest positive effects of mast cells on the preadipocyte to adipocyte transition under both physiological and pathological conditions.
- Published
- 2013
- Full Text
- View/download PDF
29. The Gata1 5' region harbors distinct cis-regulatory modules that direct gene activation in erythroid cells and gene inactivation in HSCs.
- Author
-
Takai J, Moriguchi T, Suzuki M, Yu L, Ohneda K, and Yamamoto M
- Subjects
- Animals, Cell Lineage, Cells, Cultured metabolism, Chromosomes, Artificial, Bacterial, DNA (Cytosine-5-)-Methyltransferase 1, DNA (Cytosine-5-)-Methyltransferases metabolism, DNA Methylation genetics, Enhancer Elements, Genetic genetics, Erythropoiesis genetics, GATA1 Transcription Factor physiology, GATA2 Transcription Factor metabolism, Gene Silencing, Genes, Reporter, Genes, Synthetic, Liver cytology, Liver embryology, Megakaryocytes metabolism, Mice, Mice, Transgenic, Nucleotide Motifs genetics, Sequence Deletion, Transcriptional Activation genetics, Erythroid Cells metabolism, GATA1 Transcription Factor genetics, Gene Expression Regulation, Developmental genetics, Hematopoietic Stem Cells metabolism, Regulatory Sequences, Nucleic Acid genetics
- Abstract
GATA1 is a master regulator of hematopoietic differentiation, but Gata1 expression is inactivated in hematopoietic stem cells (HSCs). Using a bacterial artificial chromosome containing the Gata1 gene modified with green fluorescent protein (GFP) reporter, we explored the function of the 3.7-kb Gata1 upstream region (GdC region) that harbors 3 core cis-elements: Gata1 hematopoietic enhancer, double GATA-motif, and CACCC-motif. Transgenic GFP expression directed by the Gata1-BAC faithfully recapitulated the endogenous Gata1 expression pattern. However, deletion of the GdC-region eliminated reporter expression in all hematopoietic cells. To test whether the combination of the core cis-elements represents the regulatory function of the GdC-region, we replaced the region with a 659-bp minigene that linked the three cis-elements (MG-GFP). The GFP reporter expression directed by the MG-GFP BAC fully recapitulated the erythroid-megakaryocytic Gata1 expression. However, the GFP expression was aberrantly increased in the HSCs and was associated with decreases in DNA methylation and abundant GATA2 binding to the transgenic MG-GFP allele. The 3.2-kb sequences interspaced between the Gata1 hematopoietic enhancer and the double GATA-motif were able to recruit DNA methyltransferase 1, thereby exerting a cis-repressive function in the HSC-like cell line. These results indicate that the 3.2-kb interspacing sequences inactivate Gata1 by maintaining DNA-methylation in the HSCs.
- Published
- 2013
- Full Text
- View/download PDF
30. GATA factor switching from GATA2 to GATA1 contributes to erythroid differentiation.
- Author
-
Suzuki M, Kobayashi-Osaki M, Tsutsumi S, Pan X, Ohmori S, Takai J, Moriguchi T, Ohneda O, Ohneda K, Shimizu R, Kanki Y, Kodama T, Aburatani H, and Yamamoto M
- Subjects
- Animals, Binding Sites, Cell Differentiation, Erythroid Cells metabolism, GATA1 Transcription Factor metabolism, GATA2 Transcription Factor metabolism, Gene Expression Regulation, Developmental, Hematopoietic Stem Cells metabolism, Mice, Mice, Transgenic, Erythroid Cells cytology, Erythropoiesis physiology, GATA1 Transcription Factor genetics, GATA2 Transcription Factor genetics, Hematopoietic Stem Cells cytology
- Abstract
Transcription factor GATA2 is highly expressed in hematopoietic stem cells and progenitors, whereas its expression declines after erythroid commitment of progenitors. In contrast, the start of GATA1 expression coincides with the erythroid commitment and increases along with the erythroid differentiation. We refer this dynamic transition of GATA factor expression to as the 'GATA factor switching'. Here, we examined contribution of the GATA factor switching to the erythroid differentiation. In Gata1-knockdown embryos that concomitantly express Gata2-GFP reporter, high-level expression of GFP reporter was detected in accumulated immature hematopoietic cells with impaired differentiation, demonstrating that GATA1 represses Gata2 gene expression in hematopoietic progenitors in vivo. We have conducted chromatin immunoprecipitation (ChIP) on microarray analyses of GATA2 and GATA1, and results indicate that the GATA1-binding sites widely overlap with the sites pre-occupied by GATA2 before the GATA1 expression. Importantly, erythroid genes harboring GATA boxes bound by both GATA1 and GATA2 tend to be expressed in immature erythroid cells, whereas those harboring GATA boxes to which GATA1 binds highly but GATA2 binds only weakly are important for the mature erythroid cell function. Our results thus support the contention that preceding binding of GATA2 helps the following binding of GATA1 and thereby secures smooth expression of the transient-phase genes., (© 2013 The Authors Genes to Cells © 2013 by the Molecular Biology Society of Japan and Wiley Publishing Asia Pty Ltd.)
- Published
- 2013
- Full Text
- View/download PDF
31. Establishment of erythroleukemic GAK14 cells and characterization of GATA1 N-terminal domain.
- Author
-
Mukai HY, Suzuki M, Nagano M, Ohmori S, Otsuki A, Tsuchida K, Moriguchi T, Ohneda K, Shimizu R, Ohneda O, and Yamamoto M
- Subjects
- Animals, Cell Lineage, Coculture Techniques, Erythroid Precursor Cells metabolism, Female, GATA1 Transcription Factor genetics, Gene Expression, Gene Knockdown Techniques, Megakaryocyte Progenitor Cells physiology, Mice, Myelopoiesis, Protein Structure, Tertiary, Amino Acids genetics, Cell Line, Tumor, Erythroid Precursor Cells physiology, Erythropoiesis, GATA1 Transcription Factor chemistry, GATA1 Transcription Factor metabolism, Leukemia, Erythroblastic, Acute
- Abstract
GATA1 is a transcription factor essential for erythropoiesis and megakaryopoiesis. It has been found that Gata1 gene knockdown heterozygous female (Gata1(G1.05/+)) mice spontaneously develop erythroblastic leukemias. In this study, we have generated a novel Gata1 knockdown erythroblastic cell line, designated GAK14, from the leukemia cells in the Gata1(G1.05/+) mice. Although GAK14 cells maintain immature phenotype on OP9 stromal cells in the presence of erythropoietin and stem cell factor, the cells produce Gr-1-, Mac1-, B220-, CD3e- or CD49b-positive hematopoietic cells when co-cultured with DAS104-8 feeder cells. However, GAK14 cells did not produce erythroid and megakaryocytic lineages, perhaps due to the absence of GATA1. Indeed, GAK14 cells became capable of differentiating into mature erythroid cells when complemented with full-length GATA1 and co-cultured with fetal liver-derived FLS5 stromal cells. This differentiation potential was impaired when GATA1 lacking the N-terminal domain was complemented. The N-terminal domain is known to contribute to the pathogenesis of transient abnormal myelopoiesis and acute megakaryoblastic leukemia related to Down syndrome. These results thus showed that GAK14 cells will serve as a powerful tool for dissecting domain function of GATA1 and that the GATA1 N-terminal domain is essential for the erythroid differentiation of GAK14 cells., (© 2013 The Authors Genes to Cells © 2013 by the Molecular Biology Society of Japan and Wiley Publishing Asia Pty Ltd.)
- Published
- 2013
- Full Text
- View/download PDF
32. Ablation of Mina53 in mice reduces allergic response in the airways.
- Author
-
Mori T, Okamoto K, Tanaka Y, Teye K, Umata T, Ohneda K, Tokuyama K, Okabe M, and Tsuneoka M
- Subjects
- Allergens immunology, Animals, Bronchoalveolar Lavage Fluid cytology, Cell Movement immunology, Eosinophils immunology, Female, Goblet Cells immunology, Immunoglobulin E blood, Interferon-gamma metabolism, Interleukin-4 metabolism, Interleukin-5 metabolism, Macrophages immunology, Male, Methacholine Chloride immunology, Mice, Mice, Inbred C57BL, Mice, Knockout, Mites immunology, Neoplasm Proteins deficiency, Nuclear Proteins deficiency, Neoplasm Proteins genetics, Neoplasm Proteins metabolism, Nuclear Proteins genetics, Nuclear Proteins metabolism, Respiratory Hypersensitivity immunology
- Abstract
The mina53 (myc-induced nuclear antigen with a 53 kDa molecular mass; also known as mina) was identified as a direct transcriptional target of the oncoprotein Myc and encodes a conserved protein in vertebrates. While Mina53 is known to be associated with tumorigenesis, it is not clear what role Mina53 plays in non-neoplastic tissues. To directly address the roles of Mina53 in non-neoplastic tissues, we created mina53-deficient mice. Both male and female mina53-deficient mice reached adulthood and were fertile, suggesting that Mina53 is dispensable for the basic developmental processes. Since we found that Mina53 was expressed in cells responsible for immune responses, we investigated whether Mina53 was involved in immune responses. When mice were exposed intranasally to house dust mites as an allergen, the airway tract showed hyperresponsiveness to methacholine in wild-type mice but not in mina53-deficient mice. The mina53-deficient mice also showed a significantly reduced migration of immune cells, including eosinophils, into bronchoalveolar lavage fluid compared with wild-type mice. The levels of Th2 cytokines, IL-4 and IL-5, produced in response to house dust mites were lower in the mina53-deficient mice than in wild-type mice. The level of IFN-γ in bronchoalveolar lavage fluid was significantly decreased by exposure to house dust mites in wild-type mice but not in the mina53-deficient mice. These results suggest that Mina53 plays a role in the allergic response to inhaled allergens, possibly through controlling IL-4 production.
- Published
- 2013
- Full Text
- View/download PDF
33. Regulation of GATA factor expression is distinct between erythroid and mast cell lineages.
- Author
-
Ohmori S, Takai J, Ishijima Y, Suzuki M, Moriguchi T, Philipsen S, Yamamoto M, and Ohneda K
- Subjects
- Animals, Bone Marrow Cells cytology, Bone Marrow Cells metabolism, Cell Lineage, Cells, Cultured, Erythroid Cells cytology, GATA1 Transcription Factor metabolism, GATA2 Transcription Factor metabolism, Histones genetics, Histones metabolism, Male, Mast Cells cytology, Mice, Mice, Knockout, Protein Binding, RNA, Messenger genetics, Cell Differentiation, Erythroid Cells metabolism, GATA1 Transcription Factor genetics, GATA2 Transcription Factor genetics, Gene Expression Regulation, Developmental, Mast Cells metabolism
- Abstract
The zinc finger transcription factors GATA1 and GATA2 participate in mast cell development. Although the expression of these factors is regulated in a cell lineage-specific and differentiation stage-specific manner, their regulation during mast cell development has not been clarified. Here, we show that the GATA2 mRNA level was significantly increased while GATA1 was maintained at low levels during the differentiation of mast cells derived from mouse bone marrow (BMMCs). Unlike in erythroid cells, forced expression or small interfering RNA (siRNA)-mediated knockdown of GATA1 rarely affected GATA2 expression, and vice versa, in mast cells, indicating the absence of cross-regulation between Gata1 and Gata2 genes. Chromatin immunoprecipitation assays revealed that both GATA factors bound to most of the conserved GATA sites of Gata1 and Gata2 loci in BMMCs. However, the GATA1 hematopoietic enhancer (G1HE) of the Gata1 gene, which is essential for GATA1 expression in erythroid and megakaryocytic lineages, was bound only weakly by both GATA factors in BMMCs. Furthermore, transgenic-mouse reporter assays revealed that the G1HE is not essential for reporter expression in BMMCs and peritoneal mast cells. Collectively, these results demonstrate that the expression of GATA factors in mast cells is regulated in a manner quite distinct from that in erythroid cells.
- Published
- 2012
- Full Text
- View/download PDF
34. GATA transcription factors are involved in IgE-dependent mast cell degranulation by enhancing the expression of phospholipase C-γ1.
- Author
-
Ishijima Y, Ohmori S, Uenishi A, and Ohneda K
- Subjects
- Animals, Bone Marrow Cells metabolism, Cell Line, Cells, Cultured, Immunoglobulin E metabolism, Mice, Rats, Cell Degranulation, GATA Transcription Factors metabolism, Mast Cells immunology, Phospholipase C gamma metabolism
- Abstract
Mast cell degranulation is a dynamic, highly organized process involving numerous signaling molecules and enzymes. Although the molecular mechanisms underlying antigen-mediated mast cell degranulation have been studied intensively, little is known about the transcriptional control of this process. Here, we show that the hematopoietic transcription factors GATA1 and GATA2 are involved in mast cell degranulation through the control of phospholipase C-γ1 (PLC-γ1) expression. Knockdown of GATA1 and/or GATA2 by specific siRNA significantly reduced antigen-induced degranulation and Ca(2+) mobilization in the rat basophilic leukemia cell line RBL-2H3. RT-PCR analyses showed that PLC-γ1 expression was significantly decreased by this GATA factor repression. Other GATA factor targets, such as the previously reported α and β subunits of the high-affinity IgE receptor (FcεRI), were unaffected. Chromatin immunoprecipitation and luciferase reporter assays demonstrated that GATA factors directly activate PLC-γ1 gene transcription through a conserved GATA-binding motif that resides in the 5'-upstream sequence. Furthermore, we show evidence that the PLC-γ1 expression is regulated by GATA2 in mast cells derived from mouse bone marrow. These data indicate that PLC-γ1 is a target gene of GATA factors in mast cells and provide evidence that GATA1 and GATA2 control antigen-mediated mast cell degranulation by regulating the expression of PLC-γ1., (© 2012 The Authors. Journal compilation © 2012 by the Molecular Biology Society of Japan/Blackwell Publishing Ltd.)
- Published
- 2012
- Full Text
- View/download PDF
35. Identification of human placenta-derived mesenchymal stem cells involved in re-endothelialization.
- Author
-
Tran TC, Kimura K, Nagano M, Yamashita T, Ohneda K, Sugimori H, Sato F, Sakakibara Y, Hamada H, Yoshikawa H, Hoang SN, and Ohneda O
- Subjects
- Animals, Bone Regeneration physiology, Cell Differentiation physiology, Female, Fractures, Bone therapy, Frizzled Receptors genetics, Frizzled Receptors metabolism, Humans, Male, Membrane Proteins genetics, Mesenchymal Stem Cell Transplantation methods, Mice, Neovascularization, Physiologic physiology, Pregnancy, Proto-Oncogene Proteins c-sis genetics, Proto-Oncogene Proteins c-sis metabolism, Receptors, G-Protein-Coupled genetics, Receptors, G-Protein-Coupled metabolism, Vascular Endothelial Growth Factor A genetics, Vascular Endothelial Growth Factor A metabolism, Endothelium, Vascular physiology, Gene Expression Regulation physiology, Membrane Proteins metabolism, Mesenchymal Stem Cells physiology, Placenta cytology
- Abstract
Human placenta is an attractive source of mesenchymal stem cells (MSC) for regenerative medicine. The cell surface markers expressed on MSC have been proposed as useful tools for the isolation of MSC from other cell populations. However, the correlation between the expression of MSC markers and the ability to support tissue regeneration in vivo has not been well examined. Here, we established several MSC lines from human placenta and examined the expression of their cell surface markers and their ability to differentiate toward mesenchymal cell lineages. We found that the expression of CD349/frizzled-9, a receptor for Wnt ligands, was positive in placenta-derived MSC. So, we isolated CD349-negative and -positive fractions from an MSC line and examined how successfully cell engraftment repaired fractured bone and recovered blood flow in ischemic regions using mouse models. CD349-negative and -positive cells displayed a similar expression pattern of cell surface markers and facilitated the repair of fractured bone in transplantation experiments in mice. Interestingly, CD349-negative, but not CD349-positive cells, showed significant effects on recovering blood flow following vascular occlusion. We found that induction of PDGFβ and bFGF mRNAs by hypoxia was greater in CD349-negative cells than in CD349-positive cells while the expression of VEGF was not significantly different in CD349-negative and CD349-positive cells. These findings suggest the possibility that CD349 could be utilized as a specialized marker for MSC isolation for re-endothelialization.
- Published
- 2011
- Full Text
- View/download PDF
36. Hypoxia responsive mesenchymal stem cells derived from human umbilical cord blood are effective for bone repair.
- Author
-
Nagano M, Kimura K, Yamashita T, Ohneda K, Nozawa D, Hamada H, Yoshikawa H, Ochiai N, and Ohneda O
- Subjects
- Adipocytes cytology, Adipocytes metabolism, Aldehyde Dehydrogenase metabolism, Alkaline Phosphatase metabolism, Angiopoietins genetics, Animals, Antigens, CD metabolism, Apoptosis Regulatory Proteins, Basic Helix-Loop-Helix Transcription Factors genetics, Cell Differentiation physiology, Cell Separation, Chondrocytes cytology, Chondrocytes metabolism, Collagen Type II genetics, Femoral Fractures pathology, Femoral Fractures therapy, Fetal Blood cytology, Gene Expression genetics, Glucose Transporter Type 1 genetics, Humans, Hypoxia-Inducible Factor 1, alpha Subunit genetics, Leukocyte Common Antigens metabolism, Lipoproteins, LDL metabolism, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells enzymology, Mesenchymal Stem Cells metabolism, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Nude, Neovascularization, Physiologic physiology, Osteoblasts cytology, Osteoblasts metabolism, Osteogenesis physiology, Receptors, CXCR4 genetics, Repressor Proteins, Vascular Endothelial Growth Factor A genetics, Cell Hypoxia physiology, Fracture Healing physiology, Mesenchymal Stem Cells cytology
- Abstract
Mesenchymal stem cells (MSCs) are highly useful in a variety of cell therapies owing to their multipotential differentiation capability. MSCs derived from umbilical cord blood are generally isolated by their plastic adherence without using specific cell surface markers and examined for their osteogenic, adipogenic, and chondrogenic differentiation properties retrospectively. Here, we report 2 subpopulations of MSCs, separated based on aldehyde dehydrogenase (ALDH) activity. MSCs with a high ALDH activity (Alde-High) proliferated more than those with a low ALDH activity (Alde-Low). Alde-High MSCs had a greater ability to differentiate than Alde-Low MSCs in in vitro culture. Transplantation of Alde-High MSCs into fractured mouse femurs enabled early repair of tissues and rapid bone substitution. Alde-High MSCs were also more responsive to hypoxia than Alde-Low MSCs, with the upregulation of Flt-1, CXCR4, and Angiopoietin-2. Thus, MSCs with a high ALDH activity might serve as an effective therapeutic tool for healing fractures within a short period of time.
- Published
- 2010
- Full Text
- View/download PDF
37. Fractionation of mature eosinophils in GATA-reporter transgenic mice.
- Author
-
Kim K, Suzuki N, Ohneda K, Minegishi N, and Yamamoto M
- Subjects
- Animals, Antigens, CD metabolism, Antigens, Differentiation metabolism, Asthma blood, Asthma immunology, Asthma pathology, Bone Marrow Cells cytology, Bone Marrow Cells metabolism, Bronchoalveolar Lavage Fluid cytology, Bronchoalveolar Lavage Fluid immunology, CCAAT-Enhancer-Binding Protein-alpha genetics, CCAAT-Enhancer-Binding Proteins genetics, Cell Count, Cell Lineage physiology, Colony-Forming Units Assay, Eosinophil Major Basic Protein genetics, Eosinophil Peroxidase genetics, Eosinophils immunology, Eosinophils metabolism, Eosinophils pathology, Flow Cytometry methods, Gene Expression genetics, Green Fluorescent Proteins genetics, Green Fluorescent Proteins metabolism, Interleukin-5 Receptor alpha Subunit genetics, Leukocytes cytology, Leukocytes metabolism, Luminescent Proteins genetics, Luminescent Proteins metabolism, Mice, Mice, Inbred BALB C, Mice, Transgenic, Nuclear Proteins genetics, Ovalbumin immunology, Receptors, Transferrin metabolism, Transcription Factors genetics, Cell Differentiation, Cell Separation methods, Eosinophils cytology, GATA1 Transcription Factor genetics, GATA2 Transcription Factor genetics, Genes, Reporter genetics
- Abstract
Eosinophils contribute to the pathophysiology of allergic and infectious diseases, albeit their molecular functions remain unknown. Mature eosinophils are identified by their unique morphology and staining characteristics. However, it is difficult to fractionate living eosinophils by flow cytometry because these granulocytes express multiple cell surface markers that are shared by other cells of hematopoietic or non-hematopoietic origin. In this study, we describe a flow cytometry-based method to enumerate and fractionate eosinophils by developmental stages. To fractionate these cell types, we used transgenic mouse lines that express fluorescent proteins under control of the Gata1 gene hematopoietic regulatory region (Gata1-HRD), which is exclusively active in Gata1-expressing hematopoietic cells, including eosinophils. As expected, mature eosinophils were highly enriched in the fluorescent reporter-expressing subfraction of bone marrow myeloid cells that were negatively selected by using multiple antibodies against B220, CD4, CD8, Ter119, c-Kit and CD71. Cytochemical analyses of flow-sorted cells identified the cells in this fraction as eosinophils harboring eosinophilic granules. Additionally, expression of eosinophil-specific genes, for instance eosinophil enzymes and the IL-5 receptor alpha gene, were specifically detected in this fraction. The expression of these eosinophil-specific genes increased as the cells differentiated. This method for enrichment of bone marrow eosinophils is applicable to fractionation of eosinophils and bronchoalveolar lavage fluid from transgenic mice with atopic asthma. Thus, both pathological and developmental stages of eosinophils are efficiently fractionated by this flow cytometry-based method using Gata1-HRD transgenic reporter mice. This study, therefore, proposes a useful means to study the experimental allergic and inflammatory systems.
- Published
- 2010
- Full Text
- View/download PDF
38. Characterization of a functional ZBP-89 binding site that mediates Gata1 gene expression during hematopoietic development.
- Author
-
Ohneda K, Ohmori S, Ishijima Y, Nakano M, and Yamamoto M
- Subjects
- Animals, Base Sequence, Binding Sites, Chromatin, Deoxyguanosine, Erythroid Cells, GATA1 Transcription Factor biosynthesis, Megakaryocytes, Mice, Mice, Transgenic, Mutation, DNA-Binding Proteins metabolism, Enhancer Elements, Genetic genetics, GATA1 Transcription Factor genetics, Hematopoiesis, Transcription Factors metabolism
- Abstract
GATA-1 is a lineage-restricted transcription factor that plays essential roles in hematopoietic development. The Gata1 gene hematopoietic enhancer allowed Gata1 reporter expression in erythroid cells and megakaryocytes of transgenic mice. The Gata1 hematopoietic enhancer activity is strictly dependent on a GATA site located in the 5' region of the enhancer. However, the importance of the GC-rich region adjacent to the 3'-end of this GATA site has been also suggested. In this study, we show that this GC-rich region contains five contiguous deoxyguanosine residues (G(5) string) that are bound by multiple nuclear proteins. Interestingly, deletion of one deoxyguanosine residue from the G(5) string (G(4) mutant) specifically eliminates binding to ZBP-89, a Krüppel-like transcription factor, but not to Sp3 and other binding factors. We demonstrate that GATA-1 and ZBP-89 occupy chromatin regions of the Gata1 enhancer and physically associate in vitro through zinc finger domains. Gel mobility shift assays and DNA affinity precipitation assays suggest that binding of ZBP-89 to this region is reduced in the absence of GATA-1 binding to the G1HE. Luciferase reporter assays demonstrate that ZBP-89 activates the Gata1 enhancer depending on the G(5) string sequence. Finally, transgenic mouse studies reveal that the G(4) mutation significantly reduced the reporter activity of the Gata1 hematopoietic regulatory domain encompassing an 8.5-kbp region of the Gata1 gene. These data provide compelling evidence that the G(5) string is necessary for Gata1 gene expression in vivo and ZBP-89 is the functional trans-acting factor for this cis-acting region.
- Published
- 2009
- Full Text
- View/download PDF
39. Differential contribution of the Gata1 gene hematopoietic enhancer to erythroid differentiation.
- Author
-
Suzuki M, Moriguchi T, Ohneda K, and Yamamoto M
- Subjects
- Amino Acid Substitution, Animals, Cell Differentiation, Cell Separation methods, Genes, Reporter, Green Fluorescent Proteins, Mice, Enhancer Elements, Genetic, Erythroid Precursor Cells cytology, Erythropoiesis genetics, GATA1 Transcription Factor genetics, Gene Expression Regulation physiology
- Abstract
GATA1 is a key regulator of erythroid cell differentiation. To examine how Gata1 gene expression is regulated in a stage-specific manner, transgenic mouse lines expressing green fluorescent protein (GFP) reporter from the Gata1 locus in a bacterial artificial chromosome (G1BAC-GFP) were prepared. We found that the GFP reporter expression faithfully recapitulated Gata1 gene expression. Using GFP fluorescence in combination with hematopoietic surface markers, we established a purification protocol for two erythroid progenitor fractions, referred to as burst-forming units-erythroid cell-related erythroid progenitor (BREP) and CFU-erythroid cell-related erythroid progenitor (CREP) fractions. We examined the functions of the Gata1 gene hematopoietic enhancer (G1HE) and the highly conserved GATA box in the enhancer core. Both deletion of the G1HE and substitution mutation of the GATA box caused almost complete loss of GFP expression in the BREP fraction, but the CREP stage expression was suppressed only partially, indicating the critical contribution of the GATA box to the BREP stage expression of Gata1. Consistently, targeted deletion of G1HE from the chromosomal Gata1 locus provoked suppressed expression of the Gata1 gene in the BREP fraction, which led to aberrant accumulation of BREP stage hematopoietic progenitor cells. These results demonstrate the physiological significance of the dynamic regulation of Gata1 gene expression in a differentiation stage-specific manner.
- Published
- 2009
- Full Text
- View/download PDF
40. The microenvironment for erythropoiesis is regulated by HIF-2alpha through VCAM-1 in endothelial cells.
- Author
-
Yamashita T, Ohneda O, Sakiyama A, Iwata F, Ohneda K, and Fujii-Kuriyama Y
- Subjects
- Anemia etiology, Animals, Basic Helix-Loop-Helix Transcription Factors deficiency, Endothelial Cells chemistry, Erythropoietin genetics, Gene Expression Regulation, Hematopoietic Stem Cell Transplantation, Mice, Mice, Knockout, Oxygen physiology, Transcription, Genetic, Basic Helix-Loop-Helix Transcription Factors physiology, Erythropoiesis, Vascular Cell Adhesion Molecule-1 genetics
- Abstract
Erythropoiesis is a dynamic process regulated by oxygen in vertebrates. Recent evidence has indicated that erythropoietin (Epo) expression is regulated by hypoxia-inducible transcription factors (HIFs), HIF-2alpha in particular. In this study, we report that knockdown mutation of HIF-2alpha in mice (kd/kd) results in normocytic anemia, despite Epo induction in response to hypoxia not being severely affected. Transplantation analyses clearly demonstrated that the hematopoietic microenvironment, but not the hematopoietic cells, was altered in kd/kd. Furthermore, cell-type specific recovery of HIF-2alpha expression in endothelial cells (ECs) abrogated the anemic condition of the kd/kd mice, indicating that HIF-2alpha in EC plays an essential role in supporting erythropoiesis. In the absence of HIF-2alpha, the expression of vascular adhesion molecule-1 (VCAM-1) was reduced significantly and restoration of VCAM-1 expression in kd/kd ECs enhanced the development of erythroid progenitors. Finally, a chromatin immunoprecipitation assay and a reporter assay indicated that VCAM-1 gene transcription is directly regulated by HIF-2alpha. These data suggest that the hematopoietic microenvironment required for erythropoiesis is dynamically regulated by oxygen through the functions of HIF-2alpha in ECs.
- Published
- 2008
- Full Text
- View/download PDF
41. Hypoxia-inducible transcription factor-2alpha in endothelial cells regulates tumor neovascularization through activation of ephrin A1.
- Author
-
Yamashita T, Ohneda K, Nagano M, Miyoshi C, Kaneko N, Miwa Y, Yamamoto M, Ohneda O, and Fujii-Kuriyama Y
- Subjects
- Animals, Endothelial Cells pathology, Ephrin-A1 antagonists & inhibitors, Ephrin-A1 genetics, Hypoxia-Inducible Factor 1, alpha Subunit genetics, Hypoxia-Inducible Factor 1, alpha Subunit metabolism, Lung Neoplasms genetics, Lung Neoplasms pathology, Melanoma genetics, Melanoma pathology, Mice, Mice, Knockout, Neoplasm Proteins antagonists & inhibitors, Neoplasm Proteins genetics, Neoplasm Transplantation, Neovascularization, Pathologic genetics, Neovascularization, Pathologic pathology, Promoter Regions, Genetic genetics, Transcription Factors genetics, Endothelial Cells metabolism, Ephrin-A1 metabolism, Lung Neoplasms metabolism, Melanoma metabolism, Neoplasm Proteins metabolism, Neovascularization, Pathologic metabolism, Transcription Factors metabolism
- Abstract
The hypoxia-inducible transcription factors (HIF)-1alpha and -2alpha mediate responses to hypoxia, such as tumor neovascularization. To determine the function of HIF-2alpha in vascular endothelial cells (ECs), we examined vascular formation in HIF-2alpha knockdown (kd/kd) mice transplanted with tumors. We observed that both the tumor size and the number of large vessels growing within transplanted melanomas were significantly reduced in kd/kd recipients compared with wild-type (WT) mice. In contrast, we observed a similar extent of vascular formation within fibrosarcomas transplanted from either kd/kd or WT mice into WT recipients. Thus, HIF-2alpha expression in host animal ECs, but not in the tumor cells, is crucial for tumor neovascularization. HIF-2alpha may function through ephrin A1 as the expression of ephrin A1 and related genes was markedly reduced in kd/kd ECs, and HIF-2alpha specifically bound a hypoxia-response element sequence in the ephrin A1 promoter. Treatment of WT ECs with an ephrin A1 inhibitor (ephrin A1-Fc) also impaired neovascularization. We conclude that in ECs, HIF-2alpha plays an essential role in vascular remodeling during tumor vascularization through activation of at least ephrin A1.
- Published
- 2008
- Full Text
- View/download PDF
42. Ablation of Gata1 in adult mice results in aplastic crisis, revealing its essential role in steady-state and stress erythropoiesis.
- Author
-
Gutiérrez L, Tsukamoto S, Suzuki M, Yamamoto-Mukai H, Yamamoto M, Philipsen S, and Ohneda K
- Subjects
- Animals, Animals, Newborn, Bone Marrow Cells drug effects, Bone Marrow Cells pathology, Cell Count, Cell Differentiation drug effects, Cell Proliferation drug effects, Erythroid Cells drug effects, Erythroid Cells pathology, Integrases metabolism, Interferons pharmacology, Megakaryocytes drug effects, Megakaryocytes pathology, Mice, Models, Biological, Spleen drug effects, Spleen pathology, Tamoxifen pharmacology, Thrombocytopenia pathology, Anemia, Aplastic genetics, Erythropoiesis drug effects, GATA1 Transcription Factor deficiency, Gene Deletion
- Abstract
The transcription factor Gata1 is expressed in several hematopoietic lineages and plays essential roles in normal hematopoietic development during embryonic stages. The lethality of Gata1-null embryos has precluded determination of its role in adult erythropoiesis. Here we have examined the effects of Gata1 loss in adult erythropoiesis using conditional Gata1 knockout mice expressing either interferon- or tamoxifen-inducible Cre recombinase (Mx-Cre and Tx-Cre, respectively). Mx-Cre-mediated Gata1 recombination, although incomplete, resulted in maturation arrest of Gata1-null erythroid cells at the proerythroblast stage, thrombocytopenia, and excessive proliferation of megakaryocytes in the spleen. Tx-Cre-mediated Gata1 recombination resulted in depletion of the erythroid compartment in bone marrow and spleen. Formation of the early and late erythroid progenitors in bone marrow was significantly reduced in the absence of Gata1. Furthermore, on treatment with a hemolytic agent, these mice failed to activate a stress erythropoietic response, despite the rising erythropoietin levels. These results indicate that, in addition to the requirement of Gata1 in adult megakaryopoiesis, Gata1 is necessary for steady-state erythropoiesis and for erythroid expansion in response to anemia. Thus, ablation of Gata1 in adult mice results in a condition resembling aplastic crisis in human.
- Published
- 2008
- Full Text
- View/download PDF
43. Abnormal heart development and lung remodeling in mice lacking the hypoxia-inducible factor-related basic helix-loop-helix PAS protein NEPAS.
- Author
-
Yamashita T, Ohneda O, Nagano M, Iemitsu M, Makino Y, Tanaka H, Miyauchi T, Goto K, Ohneda K, Fujii-Kuriyama Y, Poellinger L, and Yamamoto M
- Subjects
- Alternative Splicing genetics, Amino Acid Sequence, Animals, Apoptosis Regulatory Proteins, Basic Helix-Loop-Helix Transcription Factors chemistry, Basic Helix-Loop-Helix Transcription Factors genetics, Cell Separation, Endothelial Cells metabolism, Endothelial Cells pathology, Endothelin-1 metabolism, Gene Expression Regulation, Developmental, Gene Targeting, Lung metabolism, Lung pathology, Mice, Mice, Knockout, Molecular Sequence Data, Phenotype, RNA, Messenger genetics, RNA, Messenger metabolism, Repressor Proteins, Transcription, Genetic, Basic Helix-Loop-Helix Transcription Factors metabolism, Cardiovascular Abnormalities metabolism, Heart embryology, Lung abnormalities, Lung embryology, Transcription Factors deficiency
- Abstract
Hypoxia-inducible factors (HIFs) are crucial for oxygen homeostasis during both embryonic development and postnatal life. Here we show that a novel HIF family basic helix-loop-helix (bHLH) PAS (Per-Arnt-Sim) protein, which is expressed predominantly during embryonic and neonatal stages and thereby designated NEPAS (neonatal and embryonic PAS), acts as a negative regulator of HIF-mediated gene expression. NEPAS mRNA is derived from the HIF-3alpha gene by alternative splicing, replacing the first exon of HIF-3alpha with that of inhibitory PAS. NEPAS can dimerize with Arnt and exhibits only low levels of transcriptional activity, similar to that of HIF-3alpha. NEPAS suppressed reporter gene expression driven by HIF-1alpha and HIF-2alpha. By generating mice with a targeted disruption of the NEPAS/HIF-3alpha locus, we found that homozygous mutant mice (NEPAS/HIF-3alpha(-)(/)(-)) were viable but displayed enlargement of the right ventricle and impaired lung remodeling. The expression of endothelin 1 and platelet-derived growth factor beta was increased in the lung endothelial cells of NEPAS/HIF-3alpha-null mice. These results demonstrate a novel regulatory mechanism in which the activities of HIF-1alpha and HIF-2alpha are negatively regulated by NEPAS in endothelial cells, which is pertinent to lung and heart development during the embryonic and neonatal stages.
- Published
- 2008
- Full Text
- View/download PDF
44. Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood.
- Author
-
Nagano M, Yamashita T, Hamada H, Ohneda K, Kimura K, Nakagawa T, Shibuya M, Yoshikawa H, and Ohneda O
- Subjects
- Aldehyde Dehydrogenase analysis, Animals, Cell Movement, Cell Proliferation, Humans, Mice, Transplantation, Heterologous, Treatment Outcome, Up-Regulation genetics, Aldehyde Dehydrogenase physiology, Cell Separation methods, Endothelial Cells cytology, Fetal Blood cytology, Ischemia therapy, Stem Cell Transplantation methods, Stem Cells cytology
- Abstract
Umbilical cord blood (UCB) has been used as a potential source of various kinds of stem cells, including hematopoietic stem cells, mesenchymal stem cells, and endothelial progenitor cells (EPCs), for a variety of cell therapies. Recently, EPCs were introduced for restoring vascularization in ischemic tissues. An appropriate procedure for isolating EPCs from UCB is a key issue for improving therapeutic efficacy and eliminating the unexpected expansion of nonessential cells. Here we report a novel method for isolating EPCs from UCB by a combination of negative immunoselection and cell culture techniques. In addition, we divided EPCs into 2 subpopulations according to the aldehyde dehydrogenase (ALDH) activity. We found that EPCs with low ALDH activity (Alde-Low) possess a greater ability to proliferate and migrate compared to those with high ALDH activity (Alde-High). Moreover, hypoxia-inducible factor proteins are up-regulated and VEGF, CXCR4, and GLUT-1 mRNAs are increased in Alde-Low EPCs under hypoxic conditions, while the response was not significant in Alde-High EPCs. In fact, the introduction of Alde-Low EPCs significantly reduced tissue damage in ischemia in a mouse flap model. Thus, the introduction of Alde-Low EPCs may be a potential strategy for inducing rapid neovascularization and subsequent regeneration of ischemic tissues.
- Published
- 2007
- Full Text
- View/download PDF
45. Dynamic regulation of Gata factor levels is more important than their identity.
- Author
-
Ferreira R, Wai A, Shimizu R, Gillemans N, Rottier R, von Lindern M, Ohneda K, Grosveld F, Yamamoto M, and Philipsen S
- Subjects
- Animals, GATA Transcription Factors analysis, GATA Transcription Factors deficiency, GATA1 Transcription Factor deficiency, GATA2 Transcription Factor genetics, GATA3 Transcription Factor genetics, Mice, Mice, Knockout, Protein Biosynthesis, RNA, Messenger analysis, Regulatory Sequences, Nucleic Acid physiology, Transgenes, Erythropoiesis, GATA Transcription Factors genetics, Gene Expression Regulation physiology
- Abstract
Three Gata transcription factors (Gata1, -2, and -3) are essential for hematopoiesis. These factors are thought to play distinct roles because they do not functionally replace each other. For instance, Gata2 messenger RNA (mRNA) expression is highly elevated in Gata1-null erythroid cells, yet this does not rescue the defect. Here, we test whether Gata2 and -3 transgenes rescue the erythroid defect of Gata1-null mice, if expressed in the appropriate spatiotemporal pattern. Gata1, -2, and -3 transgenes driven by beta-globin regulatory elements, directing expression to late stages of differentiation, fail to rescue erythropoiesis in Gata1-null mutants. In contrast, when controlled by Gata1 regulatory elements, directing expression to the early stages of differentiation, Gata1, -2, and -3 do rescue the Gata1-null phenotype. The dramatic increase of endogenous Gata2 mRNA in Gata1-null progenitors is not reflected in Gata2 protein levels, invoking translational regulation. Our data show that the dynamic spatiotemporal regulation of Gata factor levels is more important than their identity and provide a paradigm for developmental control mechanisms that are hard-wired in cis-regulatory elements.
- Published
- 2007
- Full Text
- View/download PDF
46. GATA-1 self-association controls erythroid development in vivo.
- Author
-
Shimizu R, Trainor CD, Nishikawa K, Kobayashi M, Ohneda K, and Yamamoto M
- Subjects
- Acetylation, Amino Acid Substitution, Anemia genetics, Anemia metabolism, Animals, Crosses, Genetic, Embryo Loss genetics, Embryo Loss metabolism, Eosinophils cytology, Eosinophils metabolism, Erythroid Precursor Cells cytology, GATA1 Transcription Factor genetics, Heme biosynthesis, Liver cytology, Liver embryology, Mast Cells cytology, Mast Cells metabolism, Mice, Mice, Transgenic, Mutation, Missense, Protein Binding genetics, Protein Structure, Tertiary genetics, Receptors, Transferrin biosynthesis, Yolk Sac cytology, Yolk Sac embryology, Erythroid Precursor Cells metabolism, Erythropoiesis physiology, GATA1 Transcription Factor metabolism, Gene Expression Regulation, Developmental physiology, Protein Processing, Post-Translational physiology
- Abstract
GATA-1 is the key transcription factor for the development of the erythroid, megakaryocytic, eosinophilic, and mast cell lineages. GATA-1 possesses the ability to self-associate, and this characteristic has been suggested to be important for GATA-1 function. To elucidate the roles self-associated GATA-1 plays during hematopoietic cell development in vivo, in this study we prepared GATA-1 mutants in which three lysine residues potentially contributing to the self-association (Lys-245, Lys-246, and Lys-312) are substituted in combination with alanines. Of the mutants, 3KA harboring alanine substitutions in all three lysines showed reduced self-association activity without considerable interference in the modification of GATA-1 by acetylation. We generated transgenic mouse lines that express these GATA-1 mutants utilizing the Gata1 hematopoietic regulatory domain, and crossed the mice to Gata1 knockdown (GATA-1.05) mutant mice. Although NKA (K245A and K246A) and CKA (K312A) mutants almost fully rescued the GATA-1.05 mice from anemia and embryonic lethality, the 3KA mutant only partially rescued the GATA-1.05 mutant mice. Even with the higher than endogenous level expression, GATA-1.05/Y::3KA embryos were prone to die at various stages in mid-to-late gestation. Live birth and an anemic phenotype were restored in some embryos depending on the expression level of the 3KA transgene. The expression of the transferrin receptor and heme biosynthesis enzymes was impaired in the yolk sac and liver of the 3KA-rescued embryos. Immature erythroid cells with insufficient expression of the transferrin receptor accumulated in the livers of 3KA-rescued embryos. These results provide the first convincing line of evidence that the self-association of GATA-1 is important for proper mammalian erythroid development in vivo.
- Published
- 2007
- Full Text
- View/download PDF
47. GATA-4 incompletely substitutes for GATA-1 in promoting both primitive and definitive erythropoiesis in vivo.
- Author
-
Hosoya-Ohmura S, Mochizuki N, Suzuki M, Ohneda O, Ohneda K, and Yamamoto M
- Subjects
- Amino Acid Sequence, Animals, Conserved Sequence, Erythroid Cells cytology, Erythroid Cells metabolism, Erythroid Cells pathology, GATA1 Transcription Factor chemistry, GATA4 Transcription Factor chemistry, Gene Expression Regulation, Developmental, Mice, Mice, Transgenic, Molecular Sequence Data, Plasmids, Sequence Homology, Amino Acid, Transgenes, Erythropoiesis physiology, GATA1 Transcription Factor genetics, GATA1 Transcription Factor metabolism, GATA4 Transcription Factor genetics, GATA4 Transcription Factor metabolism
- Abstract
Vertebrate GATA transcription factors have been classified into two subgroups; GATA-1, GATA-2, and GATA-3 are expressed in hematopoietic cells, whereas GATA-4, GATA-5, and GATA-6 are expressed in mesoendoderm-derived tissues. We previously discovered that expression of GATA-2 or GATA-3 under the transcriptional control for the Gata1 gene eliminates lethal anemia in Gata1 germ line mutant mice (Gata1.05/Y). Here, we show that the GATA-4 expression by the same regulatory cassette prolongs the life span of Gata1.05/Y embryos from embryonic day 12.5 to 15.5 but fails to abrogate its embryonic lethality. Gata1.05/Y mice bearing the GATA-4 transgene showed impaired maturation of both primitive and definitive erythroid cells and defective erythroid cell expansion in fetal liver. Moreover, the incidence of apoptosis was observed prominently in primitive erythroid cells. In contrast, a GATA-4-GATA-1 chimeric protein prepared by linking the N-terminal region of GATA-4 to the C-terminal region of GATA-1 significantly promoted the differentiation and survival of primitive erythroid cells, although this protein is still insufficient for rescuing Gata1.05/Y embryos from lethal anemia. These data thus show a functional incompatibility between hematopoietic and endodermal GATA factors in vivo and provide evidence indicating specific roles of the C-terminal region of GATA-1 in primitive erythropoiesis.
- Published
- 2006
- Full Text
- View/download PDF
48. Real-time monitoring of stress erythropoiesis in vivo using Gata1 and beta-globin LCR luciferase transgenic mice.
- Author
-
Suzuki M, Ohneda K, Hosoya-Ohmura S, Tsukamoto S, Ohneda O, Philipsen S, and Yamamoto M
- Subjects
- Animals, Erythroid Precursor Cells cytology, Erythropoietin blood, Erythropoietin physiology, Gene Expression Regulation, Genes, Reporter, Humans, Luminescence, Methods, Mice, Mice, Transgenic, Erythropoiesis genetics, GATA1 Transcription Factor genetics, Globins genetics, Locus Control Region genetics, Luciferases genetics, Stress, Physiological genetics
- Abstract
Erythroid progenitors have the potential to proliferate rapidly in response to environmental stimuli. This process is referred to as stress erythropoiesis, with erythropoietin (EPO) playing central roles in its promotion. In this study, we wanted to elucidate the molecular mechanisms governing the regulation of stress erythropoiesis and the maintenance of red-cell homeostasis. This was achieved by our development of a noninvasive real-time monitoring system for erythropoiesis using transgenic mouse lines expressing luciferase under the control of the mouse Gata1 hematopoietic regulatory domain (G1-HRD-luc) or human beta-globin locus control region (Hbb-LCR-luc). Optical bioluminescence images revealed that the luciferase was specifically expressed in spleen and bone marrow and was induced rapidly in response to anemia and hypoxia stimuli. The G1-HRD-luc activity tracked the emergence and disappearance of proerythroblast-stage progenitors, whereas the Hbb-LCR-luc activity tracked erythroblasts and later stage erythroid cells. Increased plasma EPO concentration preceded an increase in G1-HRD-luc, supporting our contention that EPO acts as the key upstream signal in stress erythropoiesis. Hence, we conclude that G1-HRD-luc and Hbb-LCR-luc reporters are differentially activated during stress erythropoiesis and that the transgenic mouse lines used serve as an important means for understanding the homeostatic regulation of erythropoiesis.
- Published
- 2006
- Full Text
- View/download PDF
49. Graded levels of GATA-1 expression modulate survival, proliferation, and differentiation of erythroid progenitors.
- Author
-
Pan X, Ohneda O, Ohneda K, Lindeboom F, Iwata F, Shimizu R, Nagano M, Suwabe N, Philipsen S, Lim KC, Engel JD, and Yamamoto M
- Subjects
- Animals, Apoptosis, Cell Adhesion, Cell Cycle, Cell Differentiation, Cell Line, Cell Line, Tumor, Cell Lineage, Cell Proliferation, Cell Separation, Cell Survival, Cells, Cultured, Cyclin-Dependent Kinase Inhibitor p16 metabolism, DNA, Complementary metabolism, DNA-Binding Proteins chemistry, Erythrocytes metabolism, Erythroid Precursor Cells, Erythroid-Specific DNA-Binding Factors, Flow Cytometry, GATA1 Transcription Factor, Genetic Vectors, Kinetics, Liver metabolism, Mice, Models, Biological, Mutation, Retroviridae metabolism, Reverse Transcriptase Polymerase Chain Reaction, S Phase, Time Factors, Transcription Factors chemistry, DNA-Binding Proteins biosynthesis, Transcription Factors biosynthesis
- Abstract
Transcription factor GATA-1 plays an important role in gene regulation during the development of erythroid cells. Several reports suggest that GATA-1 plays multiple roles in survival, proliferation, and differentiation of erythroid cells. However, little is known about the relationship between the level of GATA-1 expression and its nature of multifunction to affect erythroid cell fate. To address this issue, we developed in vitro embryonic stem (ES) culture system by using OP9 stromal cells (OP9/ES cell co-culture system), and cultured the mutant (GATA-1.05 and GATA-1-null) and wild type (WT)ES cells, respectively. By using this OP9/ES cell co-culture system, primitive and definitive erythroid cells were developed individually, and we examined how expression level of GATA-1 affects the development of erythroid cells. GATA-1.05 ES-derived definitive erythroid cells were immature with the appearance of proerythroblasts, and highly proliferated, compared with WT and GATA-1-null ES-derived erythroid cells. Extensive studies of cell cycle kinetics revealed that the GATA-1.05 proerythroblasts accumulated in S phase and expressed lower levels of p16(INK4A) than WT ES cell-derived proerythroblasts. We concluded that GATA-1 must achieve a critical threshold activity to achieve selective activation of specific target genes, thereby influencing the developmental decision of an erythroid progenitor cell to undergo apoptosis, proliferation, or terminal differentiation.
- Published
- 2005
- Full Text
- View/download PDF
50. [Flies, fishes and frogs turn the tide of hematopoietic research].
- Author
-
Ohneda K and Yamamoto M
- Subjects
- Animals, Cell Differentiation genetics, DNA-Binding Proteins genetics, DNA-Binding Proteins physiology, Drosophila Proteins, Erythroid-Specific DNA-Binding Factors, Gene Expression Regulation, Developmental genetics, Hematopoietic Stem Cells cytology, Membrane Proteins physiology, Proto-Oncogene Proteins physiology, Receptors, Notch, Transcription Factors genetics, Vascular Endothelial Growth Factor Receptor-2 physiology, Xenopus Proteins physiology, Drosophila melanogaster, Hematopoiesis genetics, Models, Animal, Transcription Factors physiology, Xenopus laevis, Zebrafish
- Published
- 2005
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.